Bugworks Research Inc. secures US$18M Series B1 Funding from Reputed Global Investor Syndicate (The EU, UK, Japan, South Africa & India), led by Lightrock India

This Funding will advance highly differentiated assets in the dual areas of Antimicrobial Resistance (AMR) and Immuno-Oncology (IO) BANGALORE, India, SARATOGA, Calif. and ADELAIDE, Australia

Related Keywords

Germany ,Australia ,Japan ,Tokyo ,India ,Bangalore ,Karnataka ,Saratoga ,Victoria ,Adelaide ,South Australia ,Kiran Mazumdar Shaw ,Bala Subramanian ,Pooja Balachandran ,Jim Oneill ,Shahul Hameed ,Kostenloser Wertpapierhandel ,Archana Jain ,Anand Anandkumar ,Tejasvi Ravi ,Santanu Datta ,Acquipharma Holdings ,Biocon ,Global Brain Corporation ,Germany Federal Ministry Of Education ,Featherlite Group India ,Bugworks Research ,Wellcome ,University Of Tokyo Edge Capital ,Prnewswire Bugworks Research ,Bugworks Research Inc ,Kim Holdings ,Agreement Number ,Antimicrobial Resistance ,Lightrock India ,Tokyo Edge Capital ,Featherlite Group ,Lord Jimo Neill ,Executive Chairperson ,Chief Executive Officer ,Cooperative Agreement Number ,Wellcome Trust ,Federal Ministry ,Research Inc ,Bugworks ,Research ,Ecures ,Series ,Funding ,Rom ,Deputed ,Lobal ,Investor ,Yndicate ,Mouth ,Frica ,Brightrock ,